CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea
Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song
Cancer Research and Treatment. 2020;52(4):1229-1241.   Published online 2020 July 27    DOI: https://doi.org/10.4143/crt.2020.557

Excel Download

Evaluation of pemetrexed in the treatment of epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer: a retrospective study
. 2020;   Crossref logo
Link1 Link2

Chemotherapy for epithelial ovarian, fallopian tube and primary peritoneal cancer
Best Practice & Research Clinical Obstetrics & Gynaecology. 2017;41:126-138   Crossref logo
Link1 Link2

Outpatient Intraperitoneal Chemotherapy for All Stages of Ovarian, Fallopian Tube, and Peritoneal Cancers: A Pilot Study
Clinical Ovarian Cancer. 2011;4(1):7-11   Crossref logo
Link1 Link2

Frequency of germline mutations in BRIP1, RAD51C, and RAD51D among women with ovarian, primary peritoneal, and fallopian tube cancer
Gynecologic Oncology. 2017;145:43   Crossref logo
Link1 Link2

Prevalence of germline BRCA1 and BRCA2 mutations and variants among ovarian, primary peritoneal and fallopian tube cancer patients: A multicentre Indian study
Annals of Oncology. 2019;30:ix78   Crossref logo
Link1 Link2 Link3 Link4

Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review
OncoTargets and Therapy. 2015;2187   Crossref logo
Link1

Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer
Gynecologic Oncology. 2010;116(3):364-369   Crossref logo
Link1 Link2

Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: An updated series
Gynecologic Oncology. 2010;117(2):330-335   Crossref logo
Link1 Link2

Bevacizumab Combination Therapy: A Review of its Use in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
BioDrugs. 2013;27(4):375-392   Crossref logo
Link1 Link2 Link3

Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
Yearbook of Oncology. 2010;2010:58-59   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.